Clinical Trials
6 trialsNCT06083038 2026-05-06
Utilizing Continuous Glucose Monitoring to Characterize and Manage Hyperglycemia in Patients Initiating Alpelisib
HealthPartners Institute
Completed
NCT05022342 2026-02-23
SPEAR
Novartis
Completed
NCT04967248 2025-12-04
A NIS of Alpelisib in Combination With Fulvestrant in Postmenopausal Women, and Men, With HR+,HER2- , Locally Advanced or Metastatic Breast Cancer With a PIK3CA Mutation, After Disease Progression Following Endocrine Therapy as Monotherapy, in the Real-world Setting
Novartis
Terminated
NCT05293470 2025-07-09
A Post Marketing Surveillance on Piqray in Korea
Novartis
Recruiting
NCT04285723 2023-02-09
EPIK-P1
Novartis
Completed
NCT04852081 2021-04-21
Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.
Blokhin's Russian Cancer Research Center
Unknown